Pre-earnings options volume in Guardant Health (GH) is 3.2x normal with calls leading puts 9:5. Implied volatility suggests the market is anticipating a move near 9.3%, or $4.45, after results are released. Median move over the past eight quarters is 12.2%.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GH:
- GH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Guardant Health & ADPHC in deal to debut non-invasive blood-based CRC test
- Netflix upgraded, Electronic Arts downgraded: Wall Street’s top analyst calls
- Guardant Health initiated with an Overweight at Barclays
- Guardant Health price target raised to $55 from $50 at BTIG